GGrantIndex
Sort

46,585 grants matching heart failure

Assessing Syndemics of Cardiovascular Disease in People with and without HIV

$729,917
Michael J Silverberg · Kaiser Foundation Research Institute · R01 · FY2023 · HL

Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)

$729,903
Priscilla Y. Hsue · University Of California, San Francisco · R61 · FY2018 · HL

Predictors of hemorrhage among patients on direct acting oral anticoagulants

$729,872
Nita A Limdi · University Of Alabama At Birmingham · R01 · FY2023 · HL

Cardiovascular Control in Normal and Disease States

$729,851
Stephen F Vatner · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2011 · HL

Proteomics profiling in hypertrophic cardiomyopathy and cardiac event prediction

$729,819
Yuichi Shimada · Columbia University Health Sciences · R01 · FY2021 · HL

Unraveling the systemic manifestations of pulmonary arterial hypertension on lean muscle mass

$729,818
Nadine Al-Naamani · University Of Pennsylvania · R01 · FY2024 · HL

Sorting high extracellular vesicle secretors for optimal cell therapy

$729,703
Ke Cheng · Columbia Univ New York Morningside · R01 · FY2025 · HL

VACCINE DISCOVERY FOR TRYPANOSOMA CRUZI

$729,701
University Of Georgia (Uga) · P01 · FY2001 · AI

Phosphorylation-dependent regulation of calcium channels by macromolecular complexes

$729,687
Steven O Marx · Columbia University Health Sciences · R01 · FY2021 · HL

Development of the PTP1B inhibitor MSI-1436 for therapeutic stimulation of heart regeneration following acute myocardial infarction

$729,622
Viravuth P Yin · Revidia Therapeutics, Inc · R44 · FY2018 · HL

Sustaining quality of life of the aged: Heart transplant or mechanical support?

$729,587
Kathleen L Grady · Northwestern University At Chicago · R01 · FY2015 · AG

A Mobile Relational Agent to Enhance Atrial Fibrillation Self-care

$729,471
Jared W. Magnani · University Of Pittsburgh At Pittsburgh · R33 · FY2023 · HL

Immunopathogenesis of HIV-associated pulmonary hypertension

$729,401
Karen A Norris · University Of Georgia · R01 · FY2017 · HL

Multi-Omic Markers of Cardiac Function and Structure within the Pressure Overloaded Heart

$729,366
Sammy Elmariah · Massachusetts General Hospital · R01 · FY2022 · HL

Leveraging Family Data to Identify Genetic Variants for Sleep Apnea

$729,261
Susan S Redline · Brigham And Women'S Hospital · R01 · FY2016 · HL

Pharmacokinetic and Pharmacodynamic (PK-PD) Studies of Cardiovascular Drugs (U01)

$729,254
Larisa Humma Cavallari · University Of Florida · U01 · FY2016 · FD

Oligogenic Models of Cardiomyopathy

$729,239
Matthew Neil Bainbridge · Rady Pediatric Genomics & Systems Medicine Institute · R01 · FY2022 · HL

Examination of mechanisms (E-MECHANIC) of exercise-induced weight compensation

$729,236
Corby K Martin · Lsu Pennington Biomedical Research Ctr · R01 · FY2011 · HL

Phosphorylation-dependent regulation of calcium channels by macromolecular complexes

$729,194
Steven O Marx · Columbia University Health Sciences · R01 · FY2022 · HL

Vaccine Induced Immune-Inflammatory Response and Cardiovascular Risk

$729,155
Susan Cheng · Cedars-Sinai Medical Center · R01 · FY2022 · HL

Development and conduct of allogeneic stem cell transplant and autologous stem cell gene therapy for inherited immune deficiencies

$729,100
Elizabeth Kang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Genetic Determinants of Outcome in Acute Kidney Injury

$729,005
Jonathan Himmelfarb · University Of Washington · U01 · FY2012 · DK

The role of RNA binding proteins in heart development and congenital heart defects

$728,985
Muge N Kuyumcu-Martinez · University Of Virginia · R01 · FY2025 · HL

Prospective Monitoring of Newly Approved Cardiovascular Drugs in Older Adults with Frailty

$728,922
Dae Hyun Kim · Brigham And Women'S Hospital · R01 · FY2020 · AG

Innate/ SIV DNA vaccine induced immunity in the protected macaque mucosa

$728,861
Michael A Murphey-Corb · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · AI